Functional dissection of transformation by c-Src and v-Src

Genes to Cells

Volumn 13, Issue 1, 2008, Pages 1-12

  Oneyama, Chitose ^a   Hikita, Tomoya ^a   Nada, Shigeyuki ^a   Okada, Masato ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PROTEIN V SRC; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENESIS; CARCINOGENICITY; CELL TRANSFORMATION; COLON CANCER; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION PROFILING; GENE INDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NEOPLASM; NONHUMAN; ONCOGENE SRC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VASCULARIZATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; FIBROBLASTS; GENE EXPRESSION REGULATION; HEMATOMA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEIN PP60(V-SRC); PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSPLANTATION, HETEROLOGOUS;

EID: 37449034087     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2007.01145.x     Document Type: Article

References (44)

1. Akagi, T., Sasai, K. & Hanafusa, H. (2003) Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc. Natl. Acad. Sci. USA 100, 13567-13572.
2. Biscardi, J., Ishizawar, R., Silva, C. & Parsons, S. (2000) Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res. 2, 203-210.
3. Bromberg, J.F., Horvath, C.M., Besser, D., Lathem, W.W. & Darnell, J.E. Jr. (1998) Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18, 2553-2558.
4. Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C. & Darnell, J.E. Jr. (1999) Stat3 as an oncogene. Cell 98, 295-303.
5. Brown, M. & Cooper, J. (1996) Regulation, substrates and functions of src. Biochim. Biophys. Acta 1 287, 121-149.
6. Cam, W.R., Masaki, T., Shiratori, Y., Kato, N., Ikenoue, T., Okamoto, M., Igarashi, K., Sano, T. & Omata, M. (2001) Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma. Cancer 92, 61-70.
7. Cole, P., Shen, K., Qiao, Y. & Wang, D. (2003) Protein tyrosine kinases Src and Csk: A tail's tale. Curr. Opin. Chem. Biol. 7, 580-585.
8. Frame, M. (2002) Src in cancer: Deregulation and consequences for cell behaviour. Biochim. Biophys. Acta 16 02, 114-130.
9. Frame, M. (2004) Newest findings on the oldest oncogene; how activated src does it. J. Cell Sci. 117, 989-998.
10. Hakak, Y. & Martin, S. (1999) Ubiquitin-dependent degradation of active Src. Curr. Biol. 9, 1039-1042.
11. Hanks, S.K. & Polte, T.R. (1997) Signaling through focal adhesion kinase. Bioessays 19, 137-145.
12. Honda, H., Oda, H., Nakamoto, T., Honda, Z., Sakai, R., Suzuki, T., Saito, T., Nakamura, K., Nakao, K., Ishikawa, T., Katsuki, M., Yazaki, Y. & Hirai, H. (1998) Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat. Genet. 19, 361-365.
13. Imamoto, A. & Soriano, P. (1993) Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73, 1117-1124.
14. Irby, R. & Yeatman, T. (2000) Role of Src expression and activation in human cancer. Oncogene 19, 5636-5642.
15. Irby, R., Mao, W., Coppola, D., Jove, R., Gamero, A., Cuthbertson, D., Fujita, D.J. & Yeatman, T.J. (1997) Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential. Cell Growth Differ. 8, 1287-1295.
16. Irby, R., Mao, W., Coppola, D., Kang, J., Loubeau, J.M., Trudeau, W., Karl, R., Fujita, D.J., Jove, R. & Yeatman, T.J. (1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21, 187-190.
17. Ischenko, I., Guba, M., Yezhelyev, M., Papyan, A., Schmid, G., Green, T., Fennell, M., Jauch, K.W. & Bruns, C.J. (2007) Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Angiogenesis 10, 167-182.
18. Ishii, T., Onda, H., Tanigawa, A., et.al. (2005) Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res. 12, 429-439.
19. Ishizawar, R. & Parsons, S. (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6, 209-214.
20. Jove, R. & Hanafusa, H. (1987) Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol. 3, 31-56.
21. Malek, R., Irby, R., Guo, Q., Lee, K., Wong, S., He, M., Tsai, J., Frank, B., Liu, E.T., Quackenbush, J., Jove, R., Yeatman, T.J. & Lee, N.H. (2002) Identification of Src transformation fingerprint in human colon cancer. Oncogene 21, 7256-7265.
22. Masaki, T., Okada, M., Tokuda, M., Shiratori, Y., Hatase, O., Shirai, M., Nishioka, M. & Omata, M. (1999) Reduced C-Terminal Src Kinase (Csk) Activities in Hepatocellular Carcinoma. Hepatology 29, 379-384.
23. Nada, S., Okada, M., Aizawa, S. & Nakagawa, H. (1994) Identification of major tyrosine-phosphorylated proteins in Csk-deficient cells. Oncogene 9, 3571-3578.
24. Nada, S., Okada, M., MacAuley, A., Cooper, J. & Nakagawa, H. (1991) Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 351, 69-72.
25. Nada, S., Yagi, T., Takeda, H., Tokunaga, T., Nakagawa, H., Ikawa, Y., Okada, M. & Aizawa, S. (1993) Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73, 1125-1135.
26. Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R. & Yu, H. (2002) Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene 21, 7001-7010.
27. Paz, K., Socci, N., Nimwegen, V.E., Viale, A. & Darnell (2004) Transformation fingerprint: Induced STAT3-C, v-Src and Ha-Ras caise small inital changes bur similar establied profiles in mRNA. Oncogene 23, 8455-8463.
28. Penuel, E. & Martin, G. (1999) Transformation by v-Src: Ras-MAPK and PI3.K-mTOR mediate parallel pathways. Mol. Biol. Cell 10, 1693-1703.
29. Roskoski, R.J. (2004) Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 324, 1155-1164.
30. Sakai, R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y. & Hirai, H. (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13, 3748-3756.
31. Schaller, M.D., Borgman, C.A., Cobb, B.S., Vines, R.R., Reynolds, A.B. & Parsons, J.T. (1992) pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA 89, 5192-5196.
32. Schlessinger, K. & Levy, D. (2005) Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3. Cancer Res. 65, 5828-5834.
33. Segawa, Y., Suga, H., Iwabe, N., Oneyama, C., Akagi, T., Miyata, T. & Okada, M. (2006) Functional development of Src tyrosine kinases during evolution from a unicellular ancestor to multicellular animals. Proc. Natl. Acad. Sci. USA 103, 12021-12026.
34. Semenza, G. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
35. Shen, Y., Jia, Z., Nagele, R., Ichikawa, H. & Goldberg, G. (2006) Src uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells. Cancer Res. 66, 1543-1552.
36. Summy, J.M. & Gallick, G.E. (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis. Rev. 22, 337-358.
37. Sung, J., Turner, J., McCarthy, S., Enkemann, S., Li, C.G., Yan, P., Huang, T., Yeatman, T.J. (2005) Oncogene regulation of tumor suppressor genes in tumorigenesis. Carcinogenesis 26, 487-494.
38. Takeya, T. & Hanafusa, H. (1982) DNA sequence of the viral and cellular src gene of chickens. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog. J. Virol. 44, 12-18.
39. Takeya, T. & Hanafusa, H. (1983) Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell 32, 881-890.
40. Tan, M., Li, P., Klos, K., Lu, J., Lan, K.H., Nagata, Y., Fang, D., Jing, T. & Yu, D. (2005) ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis. Cancer Res. 65, 1858-1867.
41. Thomas, S., Soriano, P. & Imamoto, A. (1995) Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. Nature 376, 267-271.
42. Verderame, M., Guan, J. & Woods Ignatoski, K. (1995) Transformation and pp60v-src antophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src. Mol. Biol. Cell 6, 953-966.
43. Yeatman, T. (2004) A Renaissance For Src. Nat. Rev. Cancer 4, 470-479.
44. Yu, C., Meyer, D., Campbell, G., et.al. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83.